{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:47:18Z","timestamp":1789757238451,"version":"4.0.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:00:00Z","timestamp":1572393600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:00:00Z","timestamp":1572393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s11739-019-02215-z","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T20:26:27Z","timestamp":1572467187000},"page":"447-452","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["The risk of post-thrombotic syndrome in patients with proximal deep vein thrombosis treated with the direct oral anticoagulants"],"prefix":"10.1007","volume":"15","author":[{"name":"For the DOAC-PTS Investigators","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1285-085X","authenticated-orcid":false,"given":"Paolo","family":"Prandoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Ageno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Ciammaichella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Mumoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nello","family":"Zanatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Imberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Vison\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Bucherini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Di Nisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Noventa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,30]]},"reference":[{"issue":"2","key":"2215_CR1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","volume":"149","author":"C Kearon","year":"2016","unstructured":"Kearon C, Akl EA, Ornelas J et al (2016) Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 149(2):315\u2013352","journal-title":"Chest"},{"issue":"20","key":"2215_CR2","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1182\/blood-2018-01-785956","volume":"131","author":"A Rabinovich","year":"2018","unstructured":"Rabinovich A, Kahn SR (2018) How I treat the post-thrombotic syndrome. Blood 131(20):2215\u20132222","journal-title":"Blood"},{"issue":"9","key":"2215_CR3","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1161\/CIRCULATIONAHA.118.037425","volume":"139","author":"AJ Comerota","year":"2019","unstructured":"Comerota AJ, Kearon C, Gu CS et al (2019) Endovascular thrombus removal for acute iliofemoral deep vein thrombosis. Circulation 139(9):1162\u20131173","journal-title":"Circulation"},{"issue":"23","key":"2215_CR4","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1056\/NEJMoa1615066","volume":"377","author":"S Vedantham","year":"2017","unstructured":"Vedantham S, Goldhaber SZ, Julian JA et al (2017) Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. N Engl J Med 377(23):2240\u20132252","journal-title":"N Engl J Med"},{"key":"2215_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.thromres.2019.04.001","volume":"178","author":"P Prandoni","year":"2019","unstructured":"Prandoni P, Lensing AWA, Prins MH, Villalta S, Noventa F (2019) Determinants of severe post-thrombotic syndrome: the role of thrombus location. Thromb Res 178:171\u2013172","journal-title":"Thromb Res"},{"key":"2215_CR6","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.thromres.2019.03.003","volume":"177","author":"YM Ende-Verhaar","year":"2019","unstructured":"Ende-Verhaar YM, Tick LW, Klok FA et al (2019) Post-thrombotic syndrome: short and long-term incidence and risk factors. Thromb Res 177:102\u2013109","journal-title":"Thromb Res"},{"issue":"2","key":"2215_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1055\/s-0035-1544161","volume":"41","author":"P Prandoni","year":"2015","unstructured":"Prandoni P, Lensing AWA, Prins MH et al (2015) The impact of residual thrombosis on the long-term outcome of patients with deep venous thrombosis treated with conventional anticoagulation. Semin Thromb Hemost 41(2):133\u2013140","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"2215_CR8","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1160\/TH13-04-0336","volume":"111","author":"MP Donadini","year":"2014","unstructured":"Donadini MP, Ageno W, Antonucci E et al (2014) Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysis. Thromb Haemost 111(1):172\u2013179","journal-title":"Thromb Haemost"},{"issue":"8","key":"2215_CR9","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1055\/s-0038-1666859","volume":"118","author":"CEA Dronkers","year":"2018","unstructured":"Dronkers CEA, Mol GC, Maraziti G et al (2018) Predicting post-thrombotic syndrome with ultrasonographic follow-up after deep vein thrombosis: a systematic review and meta-analysis. Thromb Haemost 118(8):1428\u20131438","journal-title":"Thromb Haemost"},{"issue":"5","key":"2215_CR10","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/j.1538-7836.2005.01333.x","volume":"3","author":"CJ van Dongen","year":"2005","unstructured":"van Dongen CJ, Prandoni P, Frulla M, Marchiori A, Prins MH, Hutten BA (2005) Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome. J Thromb Haemost 3(5):939\u2013942","journal-title":"J Thromb Haemost"},{"issue":"2 Suppl","key":"2215_CR11","doi-asserted-by":"publisher","first-page":"e44S","DOI":"10.1378\/chest.11-2292","volume":"141","author":"W Ageno","year":"2012","unstructured":"Ageno W, Gallus AS, Wittkowsky A, Crowther M, Hylek EM, Palareti G (2012) Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):e44S\u2013e88S","journal-title":"Chest"},{"issue":"12","key":"2215_CR12","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1182\/blood-2014-04-571232","volume":"124","author":"N van Es","year":"2014","unstructured":"van Es N, Coppens M, Schulman S, Middeldorp S, B\u00fcller HR (2014) Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Blood 124(12):1968\u20131975","journal-title":"Blood"},{"key":"2215_CR13","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.thromres.2014.05.013","volume":"134","author":"P Prandoni","year":"2014","unstructured":"Prandoni P (2014) Treatment of patients with acute deep vein thrombosis and\/or pulmonary embolism: efficacy and safety of non-VKA oral anticoagulants in selected populations. Thromb Res 134:227\u2013233","journal-title":"Thromb Res"},{"issue":"4","key":"2215_CR14","first-page":"733","volume":"116","author":"YW Cheung","year":"2016","unstructured":"Cheung YW, Middeldorp S, Prins MH et al (2016) Post-thrombotic syndrome in patients treated with rivaroxaban or enoxaparin\/vitamin K antagonists for acute deep-vein thrombosis. A post hoc analysis. Thromb Haemost 116(4):733\u2013738","journal-title":"Thromb Haemost"},{"key":"2215_CR15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.thromres.2017.05.029","volume":"157","author":"L Jeraj","year":"2017","unstructured":"Jeraj L, Jezovnik MK, Poredos P (2017) Rivaroxaban versus warfarin in the prevention of post-thrombotic syndrome. Thromb Res 157:46\u201348","journal-title":"Thromb Res"},{"issue":"4","key":"2215_CR16","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1177\/1076029618758955","volume":"24","author":"CI Coleman","year":"2018","unstructured":"Coleman CI, Beyer-Westendorf J, Bunz TJ, Mahan CE, Spyropoulos AC (2018) Post-thrombotic syndrome in patients treated with rivaroxaban or warfarin for venous thromboembolism. Clin Appl Thromb Hemost 24(4):575\u2013582","journal-title":"Clin Appl Thromb Hemost"},{"key":"2215_CR17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.thromres.2018.01.013","volume":"163","author":"KK Utne","year":"2018","unstructured":"Utne KK, Dahm A, Wik HS, Jelsness-J\u00f8rgensen LP, Sandset PM, Ghanima W (2018) Rivaroxaban versus warfarin for the prevention of post-thrombotic syndrome. Thromb Res 163:6\u201311","journal-title":"Thromb Res"},{"key":"2215_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2019.05.030","author":"Soares R de Athayde","year":"2019","unstructured":"de Athayde Soares R, Matielo MF, Brochado Neto FC, Nogueira MP, Almeida RD, Sacilotto R (2019) Comparison of the recanalization rate and postthrombotic syndrome in patients with deep venous thrombosis treated with rivaroxaban or warfarin. Surgery. \nhttps:\/\/doi.org\/10.1016\/j.surg.2019.05.030\n\n(epub ahead of print)","journal-title":"Surgery"},{"key":"2215_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.thromres.2017.03.022","volume":"153","author":"P Prandoni","year":"2017","unstructured":"Prandoni P, Ageno W, Mumoli M et al (2017) Recanalization rate in patients with proximal vein thrombosis treated with the direct oral anticoagulants. Thromb Res 153:97\u2013100","journal-title":"Thromb Res"},{"issue":"18","key":"2215_CR20","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000000130","volume":"130","author":"SR Kahn","year":"2014","unstructured":"Kahn SR, Comerota AJ, Cushman M et al (2014) The post-thrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation 130(18):1636\u20131661","journal-title":"Circulation"},{"issue":"2","key":"2215_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1160\/th15-04-0318","volume":"115","author":"KK Utne","year":"2016","unstructured":"Utne KK, Ghanima W, Foyn S, Kahn S, Sandset PM, Wik HS (2016) Development and validation of a tool for patient reporting of symptoms and signs of the post-thrombotic syndrome. Thromb Haemost 115(2):361\u2013367","journal-title":"Thromb Haemost"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-019-02215-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11739-019-02215-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-019-02215-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T01:12:10Z","timestamp":1603933930000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11739-019-02215-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,30]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["2215"],"URL":"https:\/\/doi.org\/10.1007\/s11739-019-02215-z","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,30]]},"assertion":[{"value":"25 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Walter Ageno has received research support from Bayer Pharma, and honoraria for participation in advisory boards from Bayer Pharma, Boehringer Ingelheim, Daiichi Sankyo, Portola, Aspen and Sanofi. Marcello Di Nisio has received personal fees for consultancy from Bayer Pharma, BMS-Pfizer, Daiichi-Sankyo and Leo Pharma. Paolo Prandoni, Maurizio Ciammaichella, Nicola Mumoli, Nello Zanatta; Davide Imberti, Adriana Vison\u00e0, Eugenio Bucherini and Franco Noventa do not have any financial and personal relationships with other people or organizations that could inappropriately influence or bias this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the ethical board of each participating center.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human and animal rights"}},{"value":"Informed written consent was obtained from all recruited patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}